Interpace rights offering
WebPARSIPPANY, NJ, Jan. 28, 2024 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (OTCQX: IDXG) (“Interpace” or the “Company”) a leader in enabling personalized … WebJan 3, 2024 · Interpace Biosciences Announces Record Date for Proposed Fully Back-Stopped $30 Million Rights Offering January 03, 2024 17:07 ET Source: Interpace …
Interpace rights offering
Did you know?
WebJan 29, 2024 · PARSIPPANY, NJ, Jan. 28, 2024 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (OTCQX: IDXG) (“Interpace” or the “Company”) a leader in enabling personalized medicine, anno WebJan 31, 2024 · Interpace Biosciences Terminates Rights Offering Announces Change in CMS Medicare Reimbursement of its Thyroid Tests PARSIPPANY, NJ, Jan. 28, 2024 - Interpace Biosciences, Inc.... December 26, 2024
WebJan 28, 2024 · Tom Burnell, Interpace's President and CEO stated, "We are disappointed to terminate the rights offering due to the likely adverse impact of the change in CMS's … WebJan 29, 2024 · PARSIPPANY, NJ, Jan. 28, 2024 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (OTCQX: IDXG) (“Interpace” or the “Company”) a leader in enabling personalized medicine, announced today that it was terminating its previously announced rights offering and the mutual termination of the standby purchase agreement with 3K …
WebJan 29, 2024 · Tom Burnell, Interpace’s President and CEO stated, “We are disappointed to terminate the rights offering due to the likely adverse impact of the change in CMS’s … WebJan 3, 2024 · PARSIPPANY, NJ, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. ("Interpace" or the "Company") (OTCQX:IDXG) today announced that it has set the record date for its proposed fully back-stopped $30 Million Rights Offering. Under the terms of the Rights Offering, the Company will distribute non-transferable …
WebPursuant to the rights offering, the Company is distributing non-transferable Subscription Rights (the “Subscription Rights”) to purchase shares of its common stock, par value $0.01 per share (the “Common Stock”) to eligible holders of Common Stock and to holders of outstanding warrants of the Company issued on January 25, 2024, March 22, 2024, June …
WebJan 12, 2024 · The rights offering is being made only by means of a prospectus, copies of which will be delivered to eligible holders of record and can be accessed free of charge … hollow half inverted pyramid pattern in cWebJan 13, 2024 · NEW YORK — Interpace Biosciences on Wednesday said that it has commenced a previously announced $30 million rights offering. Under the terms of the … humans have 23 pairsWebProceeds to be used to fund the organic growth and prospective product line acquisitions. PARSIPPANY, NJ, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpa human shader packWebJan 3, 2024 · Interpace Biosciences () set Jan. 10 as the record date for its proposed fully back-stopped $30M rights offering.; Under the terms, the company will distribute non-transferable subscription rights ... humans hate changeWebJan 29, 2024 · PARSIPPANY, NJ, Jan. 28, 2024 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (OTCQX: IDXG) (“Interpace” or the “Company”) a leader in enabling … humans have a mysterious bioenergy fieldWeb1 day ago · The Biden Administration wants to give recipients of the Deferred Action for Childhood Arrivals program access to federal health care plans, the White House announced Thursday, as it seeks to ... human shampoo on catsWebJan 12, 2024 · PARSIPPANY, NJ, Jan. 12, 2024 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today announced that it commenced its previously announced fully back-stopped Rights Offering of up to $30 million. Under the terms of the Rights Offering, the Company is distributing non … human shared future